Disclosure Panels Details Page

Genetic/Familial High-Risk Assessment: Colorectal Panel - Disclosures as of 07/02/2022

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Date Completed
Lisen Axell MS None None None None 04/13/2022
Marian Birkeland PhD None None None None 03/08/2022
Carol Burke MD Emtora biosciences
Freenome inc
Janssen Pharmaceutica Products, LP
freenome inc
SLA pharma
None None 12/24/2021
Lee-May Chen MD AstraZeneca Pharmaceuticals LP
Genentech, Inc.
GlaxoSmithKline
None None None 03/20/2022
Daniel Chung MD Immunovia
Iterative Scopes
Janssen Pharmaceutica Products, LP
Guardant None None 03/10/2022
Katherine Clayback MS,CGC None None None None 04/22/2022
Eileen Cucinotta None None None None 06/13/2022
Susan Dallas None None None None 01/03/2022
Susan Darlow PhD None None None None 03/11/2022
Mary Dwyer MS None None None None 06/20/2022
Seth Felder MD None None None None 05/13/2022
Francis Giardiello MBA,MD None None Steinberg Gastroenterology Board Review Course None 11/23/2021
William Grady MD Diacarta
Janssen Pharmaceutica Products, LP
Lucid Technologies
Nephron
Tempus
Freenome
Guardant Health
SEngine
WebMD None 05/31/2022
Kristina Gregory OCN,MSN,RN None None None None 03/27/2022
Samir Gupta MD Epigenomics
Freenome
Cellmax
Guardant
None None 02/06/2022
Michael Hall MS,MD Caris Life Sciences
Invitae
Myriad Genetic Laboratories, Inc.
GRAIL None None 12/13/2021
Heather Hampel LGC,MS National Cancer Institute Genome Medical
GI OnDemand
Invitae Genetics
Promega
None None 10/05/2021
Rachel Hodan MS,CGC None None None None 06/06/2022
Gregory Idos MS,MD None None None None 11/19/2021
Bryson Katona MD,PhD Ambry
Freenome
GeneDx
Guardant
Immunovia
Invitae
Janssen Pharmaceutica Products, LP
Universal Diagnostics
None None None 06/13/2022
Moh'D Khushman MD AstraZeneca Pharmaceuticals LP
Bristol-Myers Squibb Company
Ipsen
Bayer HealthCare
Taiho Parmaceuticals Co., Ltd.
Pfizer Inc. None 02/25/2022
Laura Lamps MD None Ibex Medical Analytics
Scientific Symposiums International
None United States and Canadian Academy of Pathology 05/19/2022
Xavier Llor PhD,MD None None None None 03/25/2022
Patrick Lynch MD,JD SLA Pharma SLA Pharma None None 11/26/2021
Arnold Markowitz MD None None None None 05/11/2022
Mariana Niell-Swiller MS None None None None 07/01/2022
Sara Pirzadeh-Miller MS None None None None 04/18/2022
Donna Powell CMD,DHSc,RT(T) None None None None 06/21/2022
Jewel Samadder MD Cancer Prevention Pharmaceuticals
Janssen Pharmaceutica Products, LP
Cancer Prevention Pharmaceuticals
Janssen Pharmaceutica Products, LP
Recursion Pharmaceuticals
None None 12/05/2021
David Shibata MD,FACS,FASCRS None None None None 02/09/2022
Peter Stanich MD Emtora Biosciences
Freenome
Gaurdant
Invitae Corp.
Janssen Pharmaceutica Products, LP
Pfizer Inc.
PTEN Research foundation
None UpToDate, Inc. Collaborative Group of the Americas on Inherited Gastrointestinal Cancers 06/26/2022
Benjamin Swanson PhD,MD None Cogen Bioscience None Cogen Bioscience 03/29/2022
Brittany Szymaniak PhD,CGC None "Technology-enhanced AcceleRation of Germline Evaluation for Therapy - The TARGET study" which has been funded by the Prostate Cancer Foundation. UroGPO None 03/31/2022
Jennifer Weiss MD,MS Exact Sciences None American College of Physicians
Medscape
None 02/09/2022
Jeanna Welborn MD None None None None 04/29/2022
Georgia Wiesner MD None None None None 06/14/2022
Andrew Wolf MD None None None None 06/09/2022
Matthew Yurgelun MD Janssen Pharmaceutica Products, LP UpToDate None Facing Our Risk of Cancer Empowered (FORCE) advocacy group 04/29/2022